Empty Capsules Market Share, Size, Trends, Industry Analysis Report, By End-Use (Pharmaceuticals, Nutraceuticals, Cosmetic, Research Laboratories); By Type; By Functionality; By Application; By Region; Segment Forecast, 2022 - 2030
Description
The global empty capsules market size is expected to reach USD 6.44 billion by 2034 according to a new study by Polaris Market Research. The report “Empty Capsules Market Share, Size, Trends, Industry Analysis Report, By End Use (Pharmaceuticals, Nutraceuticals, Cosmetic, Research Laboratories), By Type, By Functionality, By Application, and By Region -Market Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising incidence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and gastrointestinal diseases and increasing investment in the activities for the development of therapeutic products are the driving factors for the industry growth. In addition, the availability of government funding for capsule manufacturing units, as well as the rising adoption of capsule formulations among the geriatric population, is also presenting various growth prospects to the industry expansion across the globe.
The development of halal gelatin and vegetarian pills, the emergence of new capsule delivery technologies, and the growth of the pharmaceutical industry are fostering the industry demand in the forecast years.
Based on the type, the gelatine capsules segment is dominated the global market in 2024. The gelatine pills are a safe alternative and fulfill the needed regulations for use in health & nutrition or pharmaceutical supplements. This capsule offers many numerous advantages such as uniform mixing of drugs, fast drug release, and preventing oxidation of drug molecules.
The non- gelatin capsules segment is showing the highest growth rate in the global market in the near future. The non- gelatin capsule is gaining huge traction among the vegan population, and rising R&D investments and increasing pharmaceutical expenditure are stimulating the segment growth.
Market participants such as ACG, Bright Pharma Caps, Capscanada, Capsugel, Comed Chemicals, SuHeung, Mitsubishi Chemical Holdings, Natural Capsules, Nectar Lifesciences, Qingdao Yiqing Medicinal Capsules, Roxlor, Shanxi Guangsheng Medicinal Capsule, Erawat Pharma Limited, Health Caps India, and Sunil Healthcare are some of the key players operating in the global market.
Polaris Market Research has segmented the empty capsules market report on the basis of type, functionality, application, end use, and region:
Empty Capsules, Type Outlook (Revenue - USD Billion, 2020 - 2034)
Gelatin
Porcine
Bovine
Bone Meal
Others
Non-Gelatin
Hydroxypropyl Methylcellulose (HPMC)
Pullulan and Starch Material
Empty Capsules, Functionality Outlook (Revenue - USD Billion, 2020 - 2034)
Immediate-release
Sustained-release
Delayed-release
Empty Capsules, Application Outlook (Revenue - USD Billion, 2020 - 2034)
Antibiotic & Antibacterial Drugs
Dietary Supplements
Antacid & Antiflatulent Preparations
Antianemic Preparations
Anti-inflammatory Drugs
Cardiovascular Therapy Drugs
Cough & Cold Drug Preparations
Others
Empty Capsules, By End-Use Outlook (Revenue - USD Billion, 2020 - 2034)
Pharmaceuticals
Nutraceuticals
Cosmetics
Research Laboratories
Empty Capsules, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The rising incidence of chronic diseases such as cancer, diabetes, cardiovascular diseases, and gastrointestinal diseases and increasing investment in the activities for the development of therapeutic products are the driving factors for the industry growth. In addition, the availability of government funding for capsule manufacturing units, as well as the rising adoption of capsule formulations among the geriatric population, is also presenting various growth prospects to the industry expansion across the globe.
The development of halal gelatin and vegetarian pills, the emergence of new capsule delivery technologies, and the growth of the pharmaceutical industry are fostering the industry demand in the forecast years.
Based on the type, the gelatine capsules segment is dominated the global market in 2024. The gelatine pills are a safe alternative and fulfill the needed regulations for use in health & nutrition or pharmaceutical supplements. This capsule offers many numerous advantages such as uniform mixing of drugs, fast drug release, and preventing oxidation of drug molecules.
The non- gelatin capsules segment is showing the highest growth rate in the global market in the near future. The non- gelatin capsule is gaining huge traction among the vegan population, and rising R&D investments and increasing pharmaceutical expenditure are stimulating the segment growth.
Market participants such as ACG, Bright Pharma Caps, Capscanada, Capsugel, Comed Chemicals, SuHeung, Mitsubishi Chemical Holdings, Natural Capsules, Nectar Lifesciences, Qingdao Yiqing Medicinal Capsules, Roxlor, Shanxi Guangsheng Medicinal Capsule, Erawat Pharma Limited, Health Caps India, and Sunil Healthcare are some of the key players operating in the global market.
Polaris Market Research has segmented the empty capsules market report on the basis of type, functionality, application, end use, and region:
Empty Capsules, Type Outlook (Revenue - USD Billion, 2020 - 2034)
Gelatin
Porcine
Bovine
Bone Meal
Others
Non-Gelatin
Hydroxypropyl Methylcellulose (HPMC)
Pullulan and Starch Material
Empty Capsules, Functionality Outlook (Revenue - USD Billion, 2020 - 2034)
Immediate-release
Sustained-release
Delayed-release
Empty Capsules, Application Outlook (Revenue - USD Billion, 2020 - 2034)
Antibiotic & Antibacterial Drugs
Dietary Supplements
Antacid & Antiflatulent Preparations
Antianemic Preparations
Anti-inflammatory Drugs
Cardiovascular Therapy Drugs
Cough & Cold Drug Preparations
Others
Empty Capsules, By End-Use Outlook (Revenue - USD Billion, 2020 - 2034)
Pharmaceuticals
Nutraceuticals
Cosmetics
Research Laboratories
Empty Capsules, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
112 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
- 4. Global Small Molecule Drug Discovery Outsourcing Market Insights
- 4.1. Small Molecule Drug Discovery Outsourcing Market – Market Snapshot
- 4.2. Small Molecule Drug Discovery Outsourcing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising research and development expenses
- 4.2.1.2. Increasing need for drug development
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Loss of direct control over critical processes
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Small Molecule Drug Discovery Outsourcing Market Trends
- 4.6. Value Chain Analysis
- 5. Global Small Molecule Drug Discovery Outsourcing Market, by Workflow
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 5.3. Target Identification & Screening
- 5.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Target Identification & Screening, by Region, 2020-2034 (USD Billion)
- 5.4. Target Validation & Functional Informatics
- 5.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Target Validation & Functional Informatics, by Region, 2020-2034 (USD Billion)
- 5.5. Lead Identification & Candidate Optimization
- 5.5.1. Global Small Molecule Drug Discovery Outsourcing Market, by Lead Identification & Candidate Optimization, by Region, 2020-2034 (USD Billion)
- 5.6. Preclinical Development
- 5.6.1. Global Small Molecule Drug Discovery Outsourcing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
- 5.7. Others
- 5.7.1. Global Small Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)
- 6. Global Small Molecule Drug Discovery Outsourcing Market, by Service
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 6.3. Chemistry Services
- 6.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Chemistry Services, by Region, 2020-2034 (USD Billion)
- 6.4. Biology Services
- 6.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Biology Services, by Region, 2020-2034 (USD Billion)
- 7. Global Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 7.3. Respiratory System
- 7.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Respiratory System, by Region, 2020-2034 (USD Billion)
- 7.4. Pain and Anesthesia
- 7.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Pain and Anesthesia, by Region, 2020-2034 (USD Billion)
- 7.5. Oncology
- 7.5.1. Global Small Molecule Drug Discovery Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
- 7.6. Ophthalmology
- 7.6.1. Global Small Molecule Drug Discovery Outsourcing Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
- 7.7. Hematology
- 7.7.1. Global Small Molecule Drug Discovery Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
- 7.8. Cardiovascular
- 7.8.1. Global Small Molecule Drug Discovery Outsourcing Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
- 7.9. Endocrine
- 7.9.1. Global Small Molecule Drug Discovery Outsourcing Market, by Endocrine, by Region, 2020-2034 (USD Billion)
- 7.10. Gastrointestinal
- 7.10.1. Global Small Molecule Drug Discovery Outsourcing Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)
- 7.11. Immunomodulation
- 7.11.1. Global Small Molecule Drug Discovery Outsourcing Market, by Immunomodulation, by Region, 2020-2034 (USD Billion)
- 7.12. Anti-infective
- 7.12.1. Global Small Molecule Drug Discovery Outsourcing Market, by Anti-infective, by Region, 2020-2034 (USD Billion)
- 7.13. Central Nervous System
- 7.13.1. Global Small Molecule Drug Discovery Outsourcing Market, by Central Nervous System, by Region, 2020-2034 (USD Billion)
- 7.14. Dermatology
- 7.14.1. Global Small Molecule Drug Discovery Outsourcing Market, by Dermatology, by Region, 2020-2034 (USD Billion)
- 7.15. Genitourinary System
- 7.15.1. Global Small Molecule Drug Discovery Outsourcing Market, by Genitourinary System, by Region, 2020-2034 (USD Billion)
- 8. Global Small Molecule Drug Discovery Outsourcing Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Global Small Molecule Drug Discovery Outsourcing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
- 8.4. Academic Institutes
- 8.4.1. Global Small Molecule Drug Discovery Outsourcing Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)
- 9. Global Small Molecule Drug Discovery Outsourcing Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Small Molecule Drug Discovery Outsourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Small Molecule Drug Discovery Outsourcing Market – North America
- 9.3.1. North America: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.3.2. North America: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.3.3. North America: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.3.4. North America: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5. Small Molecule Drug Discovery Outsourcing Market – US
- 9.3.5.1. US: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.3.5.2. US: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.3.5.3. US: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.3.5.4. US: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6. Small Molecule Drug Discovery Outsourcing Market – Canada
- 9.3.6.1. Canada: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4. Small Molecule Drug Discovery Outsourcing Market – Europe
- 9.4.1. Europe: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.2. Europe: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.3. Europe: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.4. Europe: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5. Small Molecule Drug Discovery Outsourcing Market – UK
- 9.4.5.1. UK: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6. Small Molecule Drug Discovery Outsourcing Market – France
- 9.4.6.1. France: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.6.2. France: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.6.3. France: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.6.4. France: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7. Small Molecule Drug Discovery Outsourcing Market – Germany
- 9.4.7.1. Germany: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8. Small Molecule Drug Discovery Outsourcing Market – Italy
- 9.4.8.1. Italy: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9. Small Molecule Drug Discovery Outsourcing Market – Spain
- 9.4.9.1. Spain: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10. Small Molecule Drug Discovery Outsourcing Market – Netherlands
- 9.4.10.1. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11. Small Molecule Drug Discovery Outsourcing Market – Russia
- 9.4.11.1. Russia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12. Small Molecule Drug Discovery Outsourcing Market – Rest of Europe
- 9.4.12.1. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5. Small Molecule Drug Discovery Outsourcing Market – Asia Pacific
- 9.5.1. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5. Small Molecule Drug Discovery Outsourcing Market – China
- 9.5.5.1. China: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.5.2. China: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.5.3. China: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.5.4. China: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6. Small Molecule Drug Discovery Outsourcing Market – India
- 9.5.6.1. India: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.6.2. India: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.6.3. India: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.6.4. India: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7. Small Molecule Drug Discovery Outsourcing Market – Malaysia
- 9.5.7.1. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8. Small Molecule Drug Discovery Outsourcing Market – Japan
- 9.5.8.1. Japan: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9. Small Molecule Drug Discovery Outsourcing Market – Indonesia
- 9.5.9.1. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10. Small Molecule Drug Discovery Outsourcing Market – South Korea
- 9.5.10.1. South Korea: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11. Small Molecule Drug Discovery Outsourcing Market – Australia
- 9.5.11.1. Australia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12. Small Molecule Drug Discovery Outsourcing Market – Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6. Small Molecule Drug Discovery Outsourcing Market – Middle East & Africa
- 9.6.1. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5. Small Molecule Drug Discovery Outsourcing Market – Saudi Arabia
- 9.6.5.1. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6. Small Molecule Drug Discovery Outsourcing Market – UAE
- 9.6.6.1. UAE: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7. Small Molecule Drug Discovery Outsourcing Market – Israel
- 9.6.7.1. Israel: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8. Small Molecule Drug Discovery Outsourcing Market – South Africa
- 9.6.8.1. South Africa: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9. Small Molecule Drug Discovery Outsourcing Market – Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7. Small Molecule Drug Discovery Outsourcing Market – Latin America
- 9.7.1. Latin America: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5. Small Molecule Drug Discovery Outsourcing Market – Mexico
- 9.7.5.1. Mexico: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6. Small Molecule Drug Discovery Outsourcing Market – Brazil
- 9.7.6.1. Brazil: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7. Small Molecule Drug Discovery Outsourcing Market – Argentina
- 9.7.7.1. Argentina: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8. Small Molecule Drug Discovery Outsourcing Market – Rest of Latin America
- 9.7.8.1. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Charles River Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Curia Global, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Eurofins Scientific
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Evotec
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. GenScript Biotech
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Labcorp
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Oncodesign
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Pharmaron
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Syngene
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Thermo Fisher Scientific Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. WuXi AppTec
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
